Wellington Management Group’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $727M | Sell |
1,478,251
-1,989,989
| -57% | -$1.08B | 0.14% | 171 |
|
|
2025
Q4 | $2.01B | Buy |
3,468,240
+768,780
| +28% | +$435M | 0.35% | 63 |
|
|
2025
Q3 | $1.31B | Buy |
2,699,460
+1,270,191
| +89% | +$591M | 0.23% | 99 |
|
|
2025
Q2 | $580M | Sell |
1,429,269
-166,446
| -10% | -$69.6M | 0.11% | 179 |
|
|
2025
Q1 | $794M | Buy |
1,595,715
+167,763
| +12% | +$90.9M | 0.15% | 142 |
|
|
2024
Q4 | $743M | Sell |
1,427,952
-1,100,685
| -44% | -$605M | 0.14% | 154 |
|
|
2024
Q3 | $1.56B | Sell |
2,528,637
-497,243
| -16% | -$294M | 0.27% | 93 |
|
|
2024
Q2 | $1.67B | Sell |
3,025,880
-44,647
| -1% | -$25.6M | 0.3% | 78 |
|
|
2024
Q1 | $1.78B | Buy |
3,070,527
+82,387
| +3% | +$46.2M | 0.32% | 79 |
|
|
2023
Q4 | $1.59B | Sell |
2,988,140
-92,547
| -3% | -$44.8M | 0.3% | 83 |
|
|
2023
Q3 | $1.56B | Buy |
3,080,687
+274,464
| +10% | +$146M | 0.31% | 75 |
|
|
2023
Q2 | $1.46B | Sell |
2,806,223
-83,893
| -3% | -$45.3M | 0.28% | 88 |
|
|
2023
Q1 | $1.67B | Sell |
2,890,116
-43,755
| -1% | -$24.7M | 0.33% | 77 |
|
|
2022
Q4 | $1.62B | Sell |
2,933,871
-2,314
| -0.1% | -$1.23M | 0.32% | 77 |
|
|
2022
Q3 | $1.49B | Sell |
2,936,185
-58,160
| -2% | -$32.5M | 0.32% | 79 |
|
|
2022
Q2 | $1.63B | Sell |
2,994,345
-21,535
| -0.7% | -$11.9M | 0.33% | 75 |
|
|
2022
Q1 | $1.78B | Sell |
3,015,880
-31,852
| -1% | -$18.3M | 0.31% | 78 |
|
|
2021
Q4 | $2.03B | Sell |
3,047,732
-146,262
| -5% | -$91.3M | 0.33% | 73 |
|
|
2021
Q3 | $1.82B | Sell |
3,193,994
-941,382
| -23% | -$517M | 0.31% | 80 |
|
|
2021
Q2 | $2.09B | Sell |
4,135,376
-1,029,608
| -20% | -$486M | 0.35% | 75 |
|
|
2021
Q1 | $2.36B | Sell |
5,164,984
-2,135,182
| -29% | -$1.02B | 0.42% | 62 |
|
|
2020
Q4 | $3.4B | Sell |
7,300,166
-425,422
| -6% | -$199M | 0.63% | 31 |
|
|
2020
Q3 | $3.41B | Sell |
7,725,588
-20,983
| -0.3% | -$8.67M | 0.71% | 30 |
|
|
2020
Q2 | $2.81B | Buy |
7,746,571
+214,446
| +3% | +$71.9M | 0.63% | 37 |
|
|
2020
Q1 | $2.14B | Sell |
7,532,125
-272,800
| -3% | -$86M | 0.57% | 42 |
|
|
2019
Q4 | $2.54B | Sell |
7,804,925
-509,625
| -6% | -$155M | 0.53% | 43 |
|
|
2019
Q3 | $2.42B | Sell |
8,314,550
-133,075
| -2% | -$38.1M | 0.55% | 44 |
|
|
2019
Q2 | $2.48B | Sell |
8,447,625
-461,953
| -5% | -$127M | 0.55% | 42 |
|
|
2019
Q1 | $2.44B | Sell |
8,909,578
-202,619
| -2% | -$50.4M | 0.55% | 41 |
|
|
2018
Q4 | $2.04B | Sell |
9,112,197
-877,542
| -9% | -$206M | 0.51% | 44 |
|
|
2018
Q3 | $2.44B | Sell |
9,989,739
-106,427
| -1% | -$24.5M | 0.51% | 42 |
|
|
2018
Q2 | $2.09B | Buy |
10,096,166
+453,879
| +5% | +$96.3M | 0.47% | 49 |
|
|
2018
Q1 | $1.99B | Buy |
9,642,287
+928,156
| +11% | +$195M | 0.45% | 51 |
|
|
2017
Q4 | $1.65B | Buy |
8,714,131
+285,484
| +3% | +$54.7M | 0.37% | 70 |
|
|
2017
Q3 | $1.59B | Buy |
8,428,647
+2,285,984
| +37% | +$414M | 0.37% | 69 |
|
|
2017
Q2 | $1.07B | Sell |
6,142,663
-1,369,489
| -18% | -$230M | 0.25% | 102 |
|
|
2017
Q1 | $1.15B | Buy |
7,512,152
+398,622
| +6% | +$60.9M | 0.28% | 91 |
|
|
2016
Q4 | $1B | Buy |
7,113,530
+448,546
| +7% | +$66.1M | 0.25% | 100 |
|
|
2016
Q3 | $1.06B | Buy |
6,664,984
+517,019
| +8% | +$79.7M | 0.27% | 92 |
|
|
2016
Q2 | $908M | Buy |
6,147,965
+12,296
| +0.2% | +$1.81M | 0.23% | 107 |
|
|
2016
Q1 | $869M | Buy |
6,135,669
+1,267,967
| +26% | +$170M | 0.23% | 111 |
|
|
2015
Q4 | $690M | Buy |
4,867,702
+124,678
| +3% | +$16.6M | 0.18% | 119 |
|
|
2015
Q3 | $580M | Buy |
4,743,024
+833,543
| +21% | +$109M | 0.16% | 138 |
|
|
2015
Q2 | $507M | Buy |
3,909,481
+520,101
| +15% | +$67.8M | 0.13% | 166 |
|
|
2015
Q1 | $455M | Buy |
3,389,380
+131,646
| +4% | +$17M | 0.12% | 178 |
|
|
2014
Q4 | $408M | Buy |
3,257,734
+879,258
| +37% | +$107M | 0.11% | 185 |
|
|
2014
Q3 | $289M | Buy |
2,378,476
+2,364,664
| +17,120% | +$288M | 0.08% | 256 |
|
|
2014
Q2 | $1.63M | Buy |
13,812
+3,483
| +34% | +$410K | ﹤0.01% | 1713 |
|
|
2014
Q1 | $1.24M | Hold |
10,329
| – | – | ﹤0.01% | 1792 |
|
|
2013
Q4 | $1.15M | Hold |
10,329
| – | – | ﹤0.01% | 1818 |
|
|
2013
Q3 | $952K | Sell |
10,329
-63,933
| -86% | -$5.78M | ﹤0.01% | 1808 |
|
|
2013
Q2 | $6.29M | Buy |
+74,262
| New | +$6.18M | ﹤0.01% | 1362 |
|
Other funds holding TMO
VCM
Wellington Management Group's TMO Position: Q1 2026 in Review
Wellington Management Group reduced its Thermo Fisher Scientific (TMO) stake by 57% in Q1 2026, selling an estimated $1.08B and leaving 1,478,251 shares worth $727M. The position accounts for 0.14% of the portfolio, ranked #171.
Wellington Management Group first reported a position in TMO in Q2 2013 and has held it in 52 quarters since. The position peaked at $3.41B in Q3 2020. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.
- Wellington Management Group held 1,478,251 shares of Thermo Fisher Scientific worth $727M as of Q1 2026.
- Wellington Management Group sold 1,989,989 Thermo Fisher Scientific shares in Q1 2026, an estimated $1.08B.
- Thermo Fisher Scientific made up 0.14% of Wellington Management Group's portfolio in Q1 2026, its #171 holding.
- Wellington Management Group first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 52 quarters since.
- Wellington Management Group's Thermo Fisher Scientific position peaked at $3.41B in Q3 2020.
- 2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.
Based on Wellington Management Group's 13F filing for Q1 2026, filed 15 May 2026.